Delivery Order SPE2DE24DA010-SPE2D625F3DN7
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract (No. 4569147994, titled "GALLANT") by the Department of Defense Medical Supply Chain on August 19, 2025, with a ceiling value of $38,345.80. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed in Santa Clara, California. The contract was awarded without set-aside designation, indicating full...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Medical Supply Chain division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, represents a delivery order under a larger indefinite delivery vehicle. This award was made through full and open competition with no set-aside designation. The place of performance is Santa Clara, California....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $1,120.00 by the Medical Supply Chain division of the Department of Defense on September 4, 2025, with an ultimate completion date of September 9, 2025. This fixed-price contract with economic price adjustment authority will be performed in Santa Clara, California. The award represents a continuation of Abbott's extensive role as a critical supplier of advanced cardiovascular...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $60,563.90 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with an ultimate completion date of September 19, 2025. The contract, designated as GALLANT (Contract Number 4569469210), was awarded without a set-aside designation, indicating full and open competition. The place of performance is located in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $39,142.80 by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025. The contract, designated GALLANT (4569455082), carries no set-aside designation, indicating full and open competition. Performance will be completed in Santa Clara, California, with an ultimate completion date of September 17, 2025. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order valued at $22,780.00 by the Medical Supply Chain division of the Department of Defense. This fixed-price delivery order with economic price adjustment was issued on September 16, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Santa Clara, California. The award was made under full and open competition with no set-aside designation. The delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on May 20, 2025, with an ultimate completion date of June 9, 2025, represents a child contract under Abbott Laboratories Inc.'s parent entity and will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $25,715.85 by the Defense Logistics Agency's Medical Supply Chain on September 5, 2025, with an ultimate completion date of September 15, 2025. The contract, which carries no set-aside designation and reflects full and open competition, is for delivery to Santa Clara, California. This delivery order represents a task order against Abbott's existing Indefinite Delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $36,320.80 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This delivery order, designated as GALLANT (Contract Number 4569403310), was issued without set-aside provisions, indicating full and open competition. The contract will be performed in Santa Clara, California, with an ultimate completion date of September 15,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order valued at $21,425.00 under contract number 4569403311 (GALLANT) by the Defense Logistics Agency's Medical Supply Chain organization. The fixed-price delivery order with economic price adjustment was awarded on September 10, 2025, with an ultimate completion date of September 15, 2025, with performance to take place in Santa Clara, California. This award represents a competitive procurement with...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F3DN7Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order (Contract No. 4568634478, GALLANT) by the Medical Supply Chain division of the Department of Defense on June 20, 2025, with an ultimate completion date of June 25, 2025. The contract, valued at $30,281.95, carries no set-aside designation, indicating full and open competition. Performance will occur at Abbott's facility in Santa Clara, California. This delivery order represents a continuation of Abbott's established role as a critical supplier of advanced cardiovascular medical technologies to federal defense and healthcare systems, drawing from the company's broader portfolio of sophisticated medical devices including stents, pacemakers, heart valves, and specialized surgical implants. This award reflects Abbott's strategic positioning within the federal healthcare procurement landscape, particularly through the Medical Supply Chain's procurement mechanisms. The fixed-price structure with economic price adjustment provisions ensures cost certainty while allowing for adjustments based on specified economic indices. Abbott Laboratories Inc. has demonstrated substantial capacity in this domain through multiple significant Indefinite Delivery Contracts, including a $117.1 million comprehensive procedural packages agreement with the Defense Logistics Agency for cardiovascular technologies and associated instrumentation. The relatively modest ceiling value of the current delivery order indicates a targeted procurement of specific medical products or services required by the Defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.3k | 6/20/25 |